News
Bio-Rad Acquires Celsee, Inc., a Single-Cell Analysis Solutions Provider
HERCULES, Calif.–April 9, 2020–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the acquisition in more detail during its first-quarter 2020 financial results conference call.
Celsee’s Genesis System offers a practical, scalable, and efficient approach to accurately analyze single cells. Using the Genesis System, scientists can isolate, analyze, and interpret cellular behavior and collect cell-based information for improved results in applications such as single-cell cytometry, single-cell transcriptomics, single-cell multiomics, rare-cell enrichment and enumeration, and immune monitoring. The system can scale from hundreds of thousands to millions of cells for genomic and proteomic applications and can enrich or monitor circulating tumor cells to determine disease progression and therapeutic response.
“We are pleased to have Celsee join Bio-Rad,” said Norman Schwartz, Bio-Rad President and CEO. “Their innovative products and technologies will extend our reach into the rapidly growing world of precision medicine and single-cell analysis, both of which offer enhanced insight into disease, diagnosis, and treatment.”
Founded in 2011 and based in Ann Arbor, Michigan, Celsee’s customers include research, translational, and biopharma laboratories worldwide.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 150,000 research and healthcare industry customers through its global network of operations. The company employs more than 8,000 people worldwide and had revenues exceeding $2.3 billion in 2019. For more information, please visit bio-rad.com.
Press Contact:
Bio-Rad Laboratories, Inc.
Tina Cuccia, Corporate Communications
510-724-7000
tina_cuccia@bio-rad.com
